Clinical Trial Update: Study to Evaluate the Safety and Efficacy of OR3O™ Dual Mobility System vs. Conventional Single Bearing Design Total Hip System [NA]

View source ↗

Summary

A terminated clinical trial evaluating the OR3O Dual Mobility System versus a conventional single bearing total hip design; results were posted in May 2025.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Avascular Necrosis of the Femoral Head
• Femoral Neck Fracture
• Hip Dislocation
• Hip Fracture
• Osteoarthritis of the Hip
• Rheumatoid Arthritis

Drugs mentioned

• OR3O Dual Mobility System

Snippet

Sponsor: Smith & Nephew Medical (Shanghai) Ltd | Conditions: Degenerative Hip Joint Disease, Rheumatoid Arthritis (RA) | NA | Status: TERMINATED | Results posted: 2025-05-21